World's Best Scientists 2026 revealed!
Rolf Kiessling

Rolf Kiessling

Award Badge
Immunology
Sweden
2026

D-Index & Metrics

Immunology

D-Index
102
Citations
36230
World Ranking
679
National Ranking
9

Medicine

D-Index
102
Citations
36253
World Ranking
7698
National Ranking
153

Rolf Kiessling publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Rolf Kiessling sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 341 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Rolf Kiessling D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Rolf Kiessling sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 102 D-Index — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in Sweden Leader Award
  • 2025 - Research.com Immunology in Sweden Leader Award
  • 2022 - Research.com Immunology in Sweden Leader Award

Overview

Rolf Kiessling is affiliated with the Karolinska Institute in Sweden. Their research primarily focuses on immunology, oncology, and molecular biology, with significant contributions to cancer immunotherapy, particularly in the field of CAR-T cell therapy and immune cell interactions within the tumor microenvironment.

Their work spans several key topics, including:

  • CAR-T cell therapy research
  • Cancer Immunotherapy and Biomarkers
  • Immune cells in cancer
  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • Neuroinflammation and Neurodegeneration Mechanisms
  • IL-33, ST2, and ILC Pathways

Kiessling has published extensively in venues such as:

  • OncoImmunology
  • Journal for ImmunoTherapy of Cancer
  • Proceedings of the National Academy of Sciences
  • Advanced Science
  • Oncogene

Frequent collaborators include Stina L. Wickström, Andreas Lundqvist, Jeroen Melief, Yago Pico de Coaña, and Yihai Cao, indicating a network of ongoing partnerships in immunology and cancer research.

Among their recent papers are:

  • "Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells", 2020, Proceedings of the National Academy of Sciences
  • "Counteracting CAR T cell dysfunction", 2020, Oncogene
  • "The Outcome of Ex Vivo TIL Expansion Is Highly Influenced by Spatial Heterogeneity of the Tumor T-Cell Repertoire and Differences in Intrinsic In Vitro Growth Capacity between T-Cell Clones", 2020, Clinical Cancer Research
  • "Targeting of Nrf2 improves antitumoral responses by human NK cells, TIL and CAR T cells during oxidative stress", 2022, Journal for ImmunoTherapy of Cancer
  • "Visualization of human T lymphocyte-mediated eradication of cancer cells in vivo", 2020, Proceedings of the National Academy of Sciences

Their research focuses heavily on understanding immune cell functions, how tumor microenvironments affect immune therapies, and the mechanisms underlying CAR-T and NK cell effectiveness against cancer cells. This includes exploring oxidative stress impacts, spatial heterogeneity of T-cell repertoires, and improving antitumoral immune responses.

Kiessling's work crosses multiple fields of study, most notably:

  • Immunology and Microbiology
  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within subfields, their research is categorized under Immunology, Oncology, Molecular Biology, Neurology, and Biomedical Engineering reflecting a broad interdisciplinary approach anchored in immune cell biology and therapeutic development.

Best Publications

  • Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy

    Klas Kärre;Hans Gustaf Ljunggren;Gerald Piontek;Rolf Kiessling

  • "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype.

    R. Kiessling;Eva Klein;H. Wigzell

  • "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell.

    R. Kiessling;Eva Klein;H. Pross;H. Wigzell;H. Wigzell

  • The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations

    Birgitta Agerberth;Jehad Charo;Joachim Werr;Berit Olsson

  • Heat-shock proteins as activators of the innate immune system

    Robert P.A Wallin;Andreas Lundqvist;Solveig H Moré;Arne von Bonin

  • Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts

    R. Kiessling;R. Kiessling;Paula S. Hochman;O. Haller;G. M. Shearer

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • Regulatory T Cells in Cancer

    Dimitrios Mougiakakos;Aniruddha Choudhury;Alvaro Lladser;Rolf Kiessling

  • Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity.

    Koji Kono;Flavio Salazar-Onfray;Max Petersson;Johan Hansson

  • Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign

    Isabel Poschke;Dimitrios Mougiakakos;Johan Hansson;Giuseppe V. Masucci

  • An analysis of the murine NK cell as to structure, function and biological relevance.

    Rolf Kiessling;Hans Wigzell

  • Decreased Expression of the Signal-transducing ζ Chains in Tumor-infiltrating T-Cells and NK Cells of Patients with Colorectal Carcinoma

    Hiroshi Nakagomi;Max Petersson;Inger Magnusson;Claes Juhlin

  • Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression.

    M Matsuda;F Salazar;M Petersson;G Masucci

  • Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo

    O. Haller;M. Hansson;R. Kiessling;H. Wigzell

  • Tumor-induced immune dysfunction.

    Rolf Kiessling;Ken Wasserman;Shigetoshi Horiguchi;Koji Kono

  • Circulating heat shock protein 60 is associated with early cardiovascular disease.

    A. Graham Pockley;Ruhia Wu;Carola Lemne;Rolf Kiessling

  • Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies.

    Pavel Pisa;Eva Halapi;Eva K. Pisa;Eva Gerdin

  • Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease.

    Masanori Matsuda;Max Petersson;Rodica Lenkei;Jean-Luc Taupin

  • Inhibition of Tumor-Derived Prostaglandin-E2 Blocks the Induction of Myeloid-Derived Suppressor Cells and Recovers Natural Killer Cell Activity

    Yumeng Mao;Dhifaf Sarhan;André Steven;Barbara Seliger

  • Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells.

    Mattias Carlsten;Håkan Norell;Yenan T. Bryceson;Isabel Poschke

  • Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non-immunized semi-syngeneic mice against a mouse lymphoma line.

    Rolf Kiessling;Gyözö Petranyi;George Klein;Hans Wigzell

  • Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines

    Aniruddha Choudhury;Jehad Charo;Sunil K. Parapuram;Richard C. Hunt

Frequent Co-Authors

Giuseppe Masucci
Giuseppe Masucci Karolinska Institute
Andreas Lundqvist
Andreas Lundqvist Karolinska Institute
Klas Kärre
Klas Kärre Karolinska Institute
Johan Hansson
Johan Hansson Karolinska Institute
George Klein
George Klein Karolinska Institute
Barbara Seliger
Barbara Seliger Martin Luther University Halle-Wittenberg
Karl-Johan Malmberg
Karl-Johan Malmberg Oslo University Hospital
Hans-Gustaf Ljunggren
Hans-Gustaf Ljunggren Karolinska Institute
Håkan Mellstedt
Håkan Mellstedt Karolinska Institute
Federica Cavallo
Federica Cavallo University of Turin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your expertise through related nursing degrees can open diverse career opportunities. Many professionals start with foundational nursing credentials before specializing further.

If you're transitioning from a non-nursing background, exploring online absn programs for non nurses provides a streamlined pathway to become a registered nurse efficiently. These programs are designed to accommodate career changers and often feature flexible online formats.

Accelerated options like the easiest accelerated nursing programs to get into help fast-track licensure and clinical experience. These programs typically require a strong commitment but can expedite your entry into healthcare roles linked to Immunology research and patient care.

For those interested in hands-on care with a shorter training period, easiest lpn programs to get into offer practical routes to assist in clinical settings. LPNs often support nurses and immunologists within healthcare teams.

Advanced practice nurses can deepen their specialization through easiest np program options, which prepare them for roles involving diagnosis, treatment, and collaboration in Immunology healthcare services.

Best Scientists Citing Rolf Kiessling

Trending Scientists

Recently Published Articles